Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title | FOA | Organization | Release Date | Expire Date Sort descending | Purpose |
---|---|---|---|---|---|
Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trail Not Allowed) | RFA-AG-25-005 | NIA | This Notice of Funding Opportunity (NOFO) invites U24 Cooperative Agreement applications that propose to establish a national Open Measurement Coordinating Network for Non-Pharmacological Alzheimer… More | ||
Diabetes Research Centers (P30 Clinical Trial Optional) | RFA-DK-25-008 | NIDDK | This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its… More | ||
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) | RFA-DC-22-001 | NIDCD | This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects… More | ||
Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional) | PAR-21-282 | NIDA | The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and limited-size clinical studies to… More | ||
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) | PAR-21-315 | NINDS | The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic… More | ||
Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) | RFA-OD-23-013 | ORWH | The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who… More | ||
Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) | RFA-OD-23-014 | ORWH | The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who… More | ||
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed) | RFA-AI-24-006 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to invite applications for Research Centers (RC) to support the Centers for Research in Emerging Infectious Diseases (CREID) Network. The… More | ||
Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (U01 Clinical Trial Not Allowed) | RFA-AI-24-016 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to invite applications for the Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (CC). The CREID… More | ||
Research Initiative for Vaccine and Antibiotic Allergy (UG3/UH3 Clinical Trial Not Allowed) | RFA-AI-24-002 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to support research that enhances understanding of the mechanisms and management of vaccine and antibiotic drug allergy. |